22nd European Congress on Alternatives to Animal Testing, August 25-28 2019, University of Linz, Austria

Opening & keynote lectures

 

 Keynote lectures

Thursday, 10 October 2019

13:15-13:45

 

Jürgen Hescheler
Director, Institute for Neurophysiology, University of Cologne, DE-Cologne
Update on human stem cells - scientific, ethical and legal challenges

Friday, 11 October 2019

09:00-09:30

 

Susanna Louhimies
Policy coordinator at the European Commission, BE-Brussels
Implementing Directive 2010/63/EU - current status and next steps

Saturday, 12 October 2019

09:00-09:30

 

Christoph Giese, DE-Berlin
Director QC and CATS at ProBioGen AG, DE-Berlin
Human Artificial Lymph Node Model (HuALN) for biopharmaceutical testing and disease modelling in vitro

Sunday, 13 October 2019

09:00-09:30

 

Mihael H. Polymeropoulos, US-Washington DC
President and CEO, Vanda Pharmaceuticals Inc., US-Washington DC
Challenging FDA’s requirement for long term studies in dogs for the safety assessment of drugs and pharmaceuticals